Primo Health is a private equity fund backing growth-oriented companies across the healthcare sector. The fund focuses on small and medium-sized enterprises operating in medical devices and equipment, the pharmaceutical supply chain, private healthcare services, and veterinary medicine. Backed by leading institutional investors, including the European Investment Fund, Fondo Italiano d’Investimento, and Fondazione ENPAM, the fund is classified as Article 8 under the SFDR, promoting ESG best practices throughout the entire investment lifecycle.